Global Heart Valve Market Report: 2011 Edition
The global heart valve market has recorded strong growth in the past years. During 2010, transcatheter aortic valve implant (TAVI) registered highest growth amongst all the segments. Tissue Valve represents the largest segment of the heart valve market with a share of nearly fifty percent. The other major market segments include mechanical valve and valve repair market.
Potential benefits and positive results of minimal invasive technology over traditional heart surgery have benefited the market to penetrate the untreated customer, thus increasing the number of surgeries. Transcatheter implants surgeries are being performed in Europe since 2007. USFDA has approved transcatheter aortic valve replacement surgery in late 2011. In response to this, the demand of mechanical valves is declining slowly and the demand of tissue valves is also likely to slow down.
The growing ageing population and increasing cases of obesity are the major factors which are driving the global heart valve market growth. Moreover, rising urban population which leads to changing lifestyle and increasing healthcare expenditure also increases the prevalence of heart diseases.
The major players in heart valve market include Edwards Lifesciences, St. Jude Medical and Medtronic. The transcatheter heart valve market is dominated by Edward Lifesciences as it enjoys first mover advantage in the US market. The industry players are continuously investing in research and development to bring out more advanced products overcoming the shortcomings of the previous one.
The report provides an analysis of the global heart valve market. It also discusses the major trends, growth drivers and potential markets for heart valve market. The report presents the competitive structure of the industry and profiles major players in the market with a discussion of their key business strategies.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
Potential benefits and positive results of minimal invasive technology over traditional heart surgery have benefited the market to penetrate the untreated customer, thus increasing the number of surgeries. Transcatheter implants surgeries are being performed in Europe since 2007. USFDA has approved transcatheter aortic valve replacement surgery in late 2011. In response to this, the demand of mechanical valves is declining slowly and the demand of tissue valves is also likely to slow down.
The growing ageing population and increasing cases of obesity are the major factors which are driving the global heart valve market growth. Moreover, rising urban population which leads to changing lifestyle and increasing healthcare expenditure also increases the prevalence of heart diseases.
The major players in heart valve market include Edwards Lifesciences, St. Jude Medical and Medtronic. The transcatheter heart valve market is dominated by Edward Lifesciences as it enjoys first mover advantage in the US market. The industry players are continuously investing in research and development to bring out more advanced products overcoming the shortcomings of the previous one.
The report provides an analysis of the global heart valve market. It also discusses the major trends, growth drivers and potential markets for heart valve market. The report presents the competitive structure of the industry and profiles major players in the market with a discussion of their key business strategies.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
1. HEART VALVES: AN OVERVIEW
2. GLOBAL HEART VALVE MARKET
Market Value
Market Segments
3. TRANSCATHETER HEART VALVE MARKET
Breakdown by Region
US Market Value
European Market Value
Share of Market Leaders
Market Penetration
Procedure Growth in US & Europe
Market Potential
4. MARKET TRENDS
4.1 Technological Advancements
4.2 Patients Profile for Valvular Heart Disease
5. KEY GROWTH DRIVERS
5.1. Increasing Aging Population
5.2 Rising Number of Obesity Cases
5.3 Increase in Healthcare Expenditure
5.4 Lifestyle Changes in Developing Countries
6. COMPETITIVE LANDSCAPE
Competitive Overview
Financial Comparison
Market Share
Global
United States
Europe
Rest of World
7. COMPANY PROFILES
7.1 Edwards Lifesciences
Business Overview
Key Financials
Business Strategies
Investment in R&D
7.2 Medtronic
Business Overview
Key Financials
Business Strategies
Innovation Strategy
Mergers & Acquisitions
7.3 St. Jude Medical
Business Overview
Key Financials
Business Strategies
Research & Development
Growth through Acquisitions
8. INDUSTRY OUTLOOK
8.1 Market Forecast
8.2 Forecast Methodology
8.2.1 Dependent and Independent Variables
8.2.2 Correlation Analysis
8.2.3 Regression Analysis
2. GLOBAL HEART VALVE MARKET
Market Value
Market Segments
3. TRANSCATHETER HEART VALVE MARKET
Breakdown by Region
US Market Value
European Market Value
Share of Market Leaders
Market Penetration
Procedure Growth in US & Europe
Market Potential
4. MARKET TRENDS
4.1 Technological Advancements
4.2 Patients Profile for Valvular Heart Disease
5. KEY GROWTH DRIVERS
5.1. Increasing Aging Population
5.2 Rising Number of Obesity Cases
5.3 Increase in Healthcare Expenditure
5.4 Lifestyle Changes in Developing Countries
6. COMPETITIVE LANDSCAPE
Competitive Overview
Financial Comparison
Market Share
Global
United States
Europe
Rest of World
7. COMPANY PROFILES
7.1 Edwards Lifesciences
Business Overview
Key Financials
Business Strategies
Investment in R&D
7.2 Medtronic
Business Overview
Key Financials
Business Strategies
Innovation Strategy
Mergers & Acquisitions
7.3 St. Jude Medical
Business Overview
Key Financials
Business Strategies
Research & Development
Growth through Acquisitions
8. INDUSTRY OUTLOOK
8.1 Market Forecast
8.2 Forecast Methodology
8.2.1 Dependent and Independent Variables
8.2.2 Correlation Analysis
8.2.3 Regression Analysis
LIST OF CHARTS
Heart Valve Market Segmentation
Global Heart Valve Market by Value, 2009-2011
Global Heart Valve Market Sales by Segments, 2001-2010
TAVI Sales by Region, 2008-2011E
Forecasted US TAVI Sales, 2010-2015E
Forecasted European TAVI Sales, 2010-2015E
TAVI Market Share by Region, 2010
Expected Surgical AVR Procedure by Region, 2011E
Global TAVI Market Revenue and Penetration Estimates, 2010-2020E
Breakdown of TAVI Procedure Estimates by Region, 2010-2015E
US TAVI Procedures, 2011E-2015E
European TAVI Procedures, 2011E-2015E
TAVI Cases by Patient Category 2010-2020E
Prevalence of Valvular Heart Disease Stratified By Age
Global Population Over 65 years of age, 2005-2012E
Worldwide Obese Population, 2004-2012F
Heart Valve Sales by Companies, 2009-H111
Heart Valve Sales by Region, 2010
Worldwide TAVI Sales Market Share, 2010-2015E
US TAVI Sales Market Share, 2010-2015E
Europe TAVI Sales Market Share, 2010-2015E
Japan and Rest of World TAVI sales Market Share, 2010-2015E
Edward’s Lifesciences Total Sales, 2008-2010
Edward’s Lifesciences Net Sales by Product Line, 2010
Medtronic’s Total Sales, 2009-2011
Medtronic Segment Sales, 2010-2011
St. Jude Medical’s Total Sales, 2007-2010
St. Jude Medical Sales by Product Categories, 2010
Heart Valve Market Forecast, 2010-2015F
Heart Valve Market Segmentation
Global Heart Valve Market by Value, 2009-2011
Global Heart Valve Market Sales by Segments, 2001-2010
TAVI Sales by Region, 2008-2011E
Forecasted US TAVI Sales, 2010-2015E
Forecasted European TAVI Sales, 2010-2015E
TAVI Market Share by Region, 2010
Expected Surgical AVR Procedure by Region, 2011E
Global TAVI Market Revenue and Penetration Estimates, 2010-2020E
Breakdown of TAVI Procedure Estimates by Region, 2010-2015E
US TAVI Procedures, 2011E-2015E
European TAVI Procedures, 2011E-2015E
TAVI Cases by Patient Category 2010-2020E
Prevalence of Valvular Heart Disease Stratified By Age
Global Population Over 65 years of age, 2005-2012E
Worldwide Obese Population, 2004-2012F
Heart Valve Sales by Companies, 2009-H111
Heart Valve Sales by Region, 2010
Worldwide TAVI Sales Market Share, 2010-2015E
US TAVI Sales Market Share, 2010-2015E
Europe TAVI Sales Market Share, 2010-2015E
Japan and Rest of World TAVI sales Market Share, 2010-2015E
Edward’s Lifesciences Total Sales, 2008-2010
Edward’s Lifesciences Net Sales by Product Line, 2010
Medtronic’s Total Sales, 2009-2011
Medtronic Segment Sales, 2010-2011
St. Jude Medical’s Total Sales, 2007-2010
St. Jude Medical Sales by Product Categories, 2010
Heart Valve Market Forecast, 2010-2015F
LIST OF TABLES
Global Heart Valve Market by Procedures, 2010
Breakdown of Patients Diagnosed with AS Worldwide, 2010-2015E
Procedural Outcomes SAVR versus TAVR
TAVI Product Approval Timeline
Annual Consumer Expenditures for Selected Components, 2008-2010
Dependent & Independent Variables (2005-2010)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
Global Heart Valve Market by Procedures, 2010
Breakdown of Patients Diagnosed with AS Worldwide, 2010-2015E
Procedural Outcomes SAVR versus TAVR
TAVI Product Approval Timeline
Annual Consumer Expenditures for Selected Components, 2008-2010
Dependent & Independent Variables (2005-2010)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
